Detalhe da pesquisa
1.
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Clin Infect Dis
; 76(3): e1177-e1185, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164254
2.
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.
J Antimicrob Chemother
; 78(11): 2702-2714, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726401
3.
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.
Mol Ther
; 29(7): 2366-2377, 2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781913
4.
Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa.
Clin Infect Dis
; 73(5): 775-782, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580234
5.
Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study.
J Antimicrob Chemother
; 72(11): 3131-3140, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961737
6.
Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
BMC Infect Dis
; 14: 662, 2014 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25466928
7.
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model.
PLoS Negl Trop Dis
; 18(4): e0012078, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640118
8.
Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27.
J Infect Dis
; 204(3): 467-77, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21742847
9.
Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissue.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1211: 123494, 2022 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219923
10.
Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients.
Clin Pharmacokinet
; 60(11): 1463-1473, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105063
11.
Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan.
PLoS Genet
; 3(5): e71, 2007 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-17500593
12.
Three-Dimensional Optical Scanning in Post-kala-azar Dermal Leishmaniasis (PKDL).
Am J Trop Med Hyg
; 102(2): 286-288, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31889505
13.
Evaluation of the particle gel diffusion technique for the detection of haemoglobin S in Sudanese patients.
Ann Clin Biochem
; 46(Pt 2): 114-6, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19164340
14.
Distribution of Duffy Phenotypes among Plasmodium vivax Infections in Sudan.
Genes (Basel)
; 10(6)2019 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31181786
15.
Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis.
Front Cell Infect Microbiol
; 8: 181, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29911074
16.
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
Clin Drug Investig
; 37(3): 259-272, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28066878
17.
Antimony-induced cerebellar ataxia.
Saudi Med J
; 27(1): 90-2, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16432602
18.
Sudanese mucosal leishmaniasis: isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis.
Infect Genet Evol
; 5(1): 29-33, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15567136
19.
Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor.
J Clin Exp Hepatol
; 4(4): 279-86, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25755574
20.
Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment.
Ann Saudi Med
; 34(2): 143-6, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894783